APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Next-Generation Sequencing (NGS) Kits

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Next-Generation Sequencing (NGS) Kits Market Outlook and Growth Opportunities 2026

Report ID 174016780431 December 2025197 pages

Choose your research edition.

Industry ResearchNext-Generation Sequencing (NGS) Kits Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Next-Generation Sequencing (NGS) Kits Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Next-Generation Sequencing (NGS) Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next-Generation Sequencing (NGS) Kits Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Next-Generation Sequencing (NGS) Kits Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Next-Generation Sequencing (NGS) Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Next-Generation Sequencing (NGS) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Next-Generation Sequencing (NGS) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Next-Generation Sequencing (NGS) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Next-Generation Sequencing (NGS) Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Next-Generation Sequencing (NGS) Kits market include Amoydxmed, Foundation Medicine, Illumina, MSKCC, Novogene, Nanjing Geneseeq, Burning Rock Biotech and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Next-Generation Sequencing (NGS) Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Next-Generation Sequencing (NGS) Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Next-Generation Sequencing (NGS) Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Next-Generation Sequencing (NGS) Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

Next-Generation Sequencing (NGS) Kits Segment by Company

Amoydxmed

Foundation Medicine

Illumina

MSKCC

Novogene

Nanjing Geneseeq

Burning Rock Biotech

Thermo Fisher Scientific

Next-Generation Sequencing (NGS) Kits Segment by Type

BRAF

BRCA

EGFR

Others

Next-Generation Sequencing (NGS) Kits Segment by Application

Research Organizations

Hospitals and Clinics

Biopharma Companies

Others

Next-Generation Sequencing (NGS) Kits Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Next-Generation Sequencing (NGS) Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Next-Generation Sequencing (NGS) Kits market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Next-Generation Sequencing (NGS) Kits significant trends, drivers, influence factors in global and regions.

6. To analyze Next-Generation Sequencing (NGS) Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing (NGS) Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing (NGS) Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing (NGS) Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Next-Generation Sequencing (NGS) Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next-Generation Sequencing (NGS) Kits industry.

Chapter 3: Detailed analysis of Next-Generation Sequencing (NGS) Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Next-Generation Sequencing (NGS) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Next-Generation Sequencing (NGS) Kits in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Next-Generation Sequencing (NGS) Kits Industry Trends Table 2. Next-Generation Sequencing (NGS) Kits Industry Drivers Table 3. Next-Generation Sequencing (NGS) Kits Industry Opportunities and Challenges Table 4. Next-Generation Sequencing (NGS) Kits Industry Restraints Table 5. Global Next-Generation Sequencing (NGS) Kits Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Next-Generation Sequencing (NGS) Kits Revenue Share by Company (2021-2026) Table 7. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Company (K Pairs) & (2021-2026) Table 8. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Company (2021-2026) Table 9. Global Next-Generation Sequencing (NGS) Kits Average Price (US$ Million) of Company (2021-2026) Table 10. Global Next-Generation Sequencing (NGS) Kits Company Ranking, (2024-2026) & (USD Million) Table 11. Global Next-Generation Sequencing (NGS) Kits Key Company Manufacturing Base & Headquarters Table 12. Global Next-Generation Sequencing (NGS) Kits Company, Product Type & Application Table 13. Global Next-Generation Sequencing (NGS) Kits Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Next-Generation Sequencing (NGS) Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of BRAF Table 18. Significant Companies of BRCA Table 19. Significant Companies of EGFR Table 20. Significant Companies of Others Table 21. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type 2021 VS 2025 VS 2032 (K Pairs) Table 22. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type (2021-2026) & (K Pairs) Table 23. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type (2027-2032) & (K Pairs) Table 24. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Type (2021-2026) Table 25. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Type (2027-2032) Table 26. Global Next-Generation Sequencing (NGS) Kits Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Next-Generation Sequencing (NGS) Kits Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Next-Generation Sequencing (NGS) Kits Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Type (2021-2026) Table 30. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Research Organizations Table 32. Significant Companies of Hospitals and Clinics Table 33. Significant Companies of Biopharma Companies Table 34. Significant Companies of Others Table 35. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application 2021 VS 2025 VS 2032 (K Pairs) Table 36. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application (2021-2026) & (K Pairs) Table 37. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application (2027-2032) & (K Pairs) Table 38. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Application (2021-2026) Table 39. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Application (2027-2032) Table 40. Global Next-Generation Sequencing (NGS) Kits Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Next-Generation Sequencing (NGS) Kits Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Next-Generation Sequencing (NGS) Kits Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Application (2021-2026) Table 44. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Application (2027-2032) Table 45. Global Next-Generation Sequencing (NGS) Kits Sales by Region: 2021 VS 2025 VS 2032 (K Pairs) Table 46. Global Next-Generation Sequencing (NGS) Kits Sales by Region (2021-2026) & (K Pairs) Table 47. Global Next-Generation Sequencing (NGS) Kits Sales Market Share by Region (2021-2026) Table 48. Global Next-Generation Sequencing (NGS) Kits Sales by Region (2027-2032) & (K Pairs) Table 49. Global Next-Generation Sequencing (NGS) Kits Sales Market Share by Region (2027-2032) Table 50. Global Next-Generation Sequencing (NGS) Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Next-Generation Sequencing (NGS) Kits Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Region (2021-2026) Table 53. Global Next-Generation Sequencing (NGS) Kits Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Region (2027-2032) Table 55. Global Next-Generation Sequencing (NGS) Kits Market Average Price (US$ Million) by Region (2021-2026) Table 56. Global Next-Generation Sequencing (NGS) Kits Market Average Price (US$ Million) by Region (2027-2032) Table 57. Global Next-Generation Sequencing (NGS) Kits Sales by Country: 2021 VS 2025 VS 2032 (K Pairs) Table 58. Global Next-Generation Sequencing (NGS) Kits Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Next-Generation Sequencing (NGS) Kits Sales by Country (2021-2026) & (K Pairs) Table 60. Global Next-Generation Sequencing (NGS) Kits Sales Market Share by Country (2021-2026) Table 61. Global Next-Generation Sequencing (NGS) Kits Sales by Country (2027-2032) & (K Pairs) Table 62. Global Next-Generation Sequencing (NGS) Kits Sales Market Share by Country (2027-2032) Table 63. Global Next-Generation Sequencing (NGS) Kits Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Next-Generation Sequencing (NGS) Kits Sales Value Market Share by Country (2021-2026) Table 65. Global Next-Generation Sequencing (NGS) Kits Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Next-Generation Sequencing (NGS) Kits Sales Value Market Share by Country (2027-2032) Table 67. Amoydxmed Company Information Table 68. Amoydxmed Business Overview Table 69. Amoydxmed Next-Generation Sequencing (NGS) Kits Sales (K Pairs), Value (US$ Million), Price (US$ Million) and Gross Margin (2021-2026) Table 70. Amoydxmed Next-Generation Sequencing (NGS) Kits Product Portfolio Table 71. Amoydxmed Recent Development Table 72. Foundation Medicine Company Information Table 73. Foundation Medicine Business Overview Table 74. Foundation Medicine Next-Generation Sequencing (NGS) Kits Sales (K Pairs), Value (US$ Million), Price (US$ Million) and Gross Margin (2021-2026) Table 75. Foundation Medicine Next-Generation Sequencing (NGS) Kits Product Portfolio Table 76. Foundation Medicine Recent Development Table 77. Illumina Company Information Table 78. Illumina Business Overview Table 79. Illumina Next-Generation Sequencing (NGS) Kits Sales (K Pairs), Value (US$ Million), Price (US$ Million) and Gross Margin (2021-2026) Table 80. Illumina Next-Generation Sequencing (NGS) Kits Product Portfolio Table 81. Illumina Recent Development Table 82. MSKCC Company Information Table 83. MSKCC Business Overview Table 84. MSKCC Next-Generation Sequencing (NGS) Kits Sales (K Pairs), Value (US$ Million), Price (US$ Million) and Gross Margin (2021-2026) Table 85. MSKCC Next-Generation Sequencing (NGS) Kits Product Portfolio Table 86. MSKCC Recent Development Table 87. Novogene Company Information Table 88. Novogene Business Overview Table 89. Novogene Next-Generation Sequencing (NGS) Kits Sales (K Pairs), Value (US$ Million), Price (US$ Million) and Gross Margin (2021-2026) Table 90. Novogene Next-Generation Sequencing (NGS) Kits Product Portfolio Table 91. Novogene Recent Development Table 92. Nanjing Geneseeq Company Information Table 93. Nanjing Geneseeq Business Overview Table 94. Nanjing Geneseeq Next-Generation Sequencing (NGS) Kits Sales (K Pairs), Value (US$ Million), Price (US$ Million) and Gross Margin (2021-2026) Table 95. Nanjing Geneseeq Next-Generation Sequencing (NGS) Kits Product Portfolio Table 96. Nanjing Geneseeq Recent Development Table 97. Burning Rock Biotech Company Information Table 98. Burning Rock Biotech Business Overview Table 99. Burning Rock Biotech Next-Generation Sequencing (NGS) Kits Sales (K Pairs), Value (US$ Million), Price (US$ Million) and Gross Margin (2021-2026) Table 100. Burning Rock Biotech Next-Generation Sequencing (NGS) Kits Product Portfolio Table 101. Burning Rock Biotech Recent Development Table 102. Thermo Fisher Scientific Company Information Table 103. Thermo Fisher Scientific Business Overview Table 104. Thermo Fisher Scientific Next-Generation Sequencing (NGS) Kits Sales (K Pairs), Value (US$ Million), Price (US$ Million) and Gross Margin (2021-2026) Table 105. Thermo Fisher Scientific Next-Generation Sequencing (NGS) Kits Product Portfolio Table 106. Thermo Fisher Scientific Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Next-Generation Sequencing (NGS) Kits Distributors List Table 110. Next-Generation Sequencing (NGS) Kits Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Next-Generation Sequencing (NGS) Kits Product Image Figure 2. Global Next-Generation Sequencing (NGS) Kits Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032) & (US$ Million) Figure 4. Global Next-Generation Sequencing (NGS) Kits Sales (2021-2032) & (K Pairs) Figure 5. Global Next-Generation Sequencing (NGS) Kits Sales Average Price (US$ Million) & (2021-2032) Figure 6. Global Next-Generation Sequencing (NGS) Kits Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. BRAF Image Figure 10. BRCA Image Figure 11. EGFR Image Figure 12. Others Image Figure 13. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type (2021 VS 2025 VS 2032) & (K Pairs) Figure 14. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Type (2021-2032) Figure 16. Global Next-Generation Sequencing (NGS) Kits Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Next-Generation Sequencing (NGS) Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Type (2021-2032) Figure 19. Research Organizations Image Figure 20. Hospitals and Clinics Image Figure 21. Biopharma Companies Image Figure 22. Others Image Figure 23. Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application (2021 VS 2025 VS 2032) & (K Pairs) Figure 24. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Application (2021-2032) Figure 26. Global Next-Generation Sequencing (NGS) Kits Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Next-Generation Sequencing (NGS) Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Application (2021-2032) Figure 29. Global Next-Generation Sequencing (NGS) Kits Sales by Region: 2021 VS 2025 VS 2032 (K Pairs) Figure 30. Global Next-Generation Sequencing (NGS) Kits Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Next-Generation Sequencing (NGS) Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032) & (US$ Million) Figure 34. North America Next-Generation Sequencing (NGS) Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Next-Generation Sequencing (NGS) Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Next-Generation Sequencing (NGS) Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032) & (US$ Million) Figure 40. South America Next-Generation Sequencing (NGS) Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Next-Generation Sequencing (NGS) Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Next-Generation Sequencing (NGS) Kits Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Next-Generation Sequencing (NGS) Kits Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • BRAF
  • BRCA
  • EGFR
  • Others
Applications
  • Research Organizations
  • Hospitals and Clinics
  • Biopharma Companies
  • Others
Companies covered
  • Amoydxmed
  • Foundation Medicine
  • Illumina
  • MSKCC
  • Novogene
  • Nanjing Geneseeq
  • Burning Rock Biotech
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032)
  4. 1.2.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume (2021-2032)
  5. 1.2.3 Global Next-Generation Sequencing (NGS) Kits Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Next-Generation Sequencing (NGS) Kits Market Dynamics
  1. 2.1 Next-Generation Sequencing (NGS) Kits Industry Trends
  2. 2.2 Next-Generation Sequencing (NGS) Kits Industry Drivers
  3. 2.3 Next-Generation Sequencing (NGS) Kits Industry Opportunities and Challenges
  4. 2.4 Next-Generation Sequencing (NGS) Kits Industry Restraints
3 Next-Generation Sequencing (NGS) Kits Market by Company
  1. 3.1 Global Next-Generation Sequencing (NGS) Kits Company Revenue Ranking in 2025
  2. 3.2 Global Next-Generation Sequencing (NGS) Kits Revenue by Company (2021-2026)
  3. 3.3 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Company (2021-2026)
  4. 3.4 Global Next-Generation Sequencing (NGS) Kits Average Price by Company (2021-2026)
  5. 3.5 Global Next-Generation Sequencing (NGS) Kits Company Ranking (2024-2026)
  6. 3.6 Global Next-Generation Sequencing (NGS) Kits Company Manufacturing Base and Headquarters
  7. 3.7 Global Next-Generation Sequencing (NGS) Kits Company Product Type and Application
  8. 3.8 Global Next-Generation Sequencing (NGS) Kits Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Next-Generation Sequencing (NGS) Kits Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Next-Generation Sequencing (NGS) Kits Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Next-Generation Sequencing (NGS) Kits Market by Type
  1. 4.1 Next-Generation Sequencing (NGS) Kits Type Introduction
  2. 4.1.1 BRAF
  3. 4.1.2 BRCA
  4. 4.1.3 EGFR
  5. 4.1.4 Others
  6. 4.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type
  7. 4.2.1 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Next-Generation Sequencing (NGS) Kits Sales Value by Type
  11. 4.3.1 Global Next-Generation Sequencing (NGS) Kits Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Type (2021-2032)
  13. 4.3.3 Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Type (2021-2032)
5 Next-Generation Sequencing (NGS) Kits Market by Application
  1. 5.1 Next-Generation Sequencing (NGS) Kits Application Introduction
  2. 5.1.1 Research Organizations
  3. 5.1.2 Hospitals and Clinics
  4. 5.1.3 Biopharma Companies
  5. 5.1.4 Others
  6. 5.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application
  7. 5.2.1 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Next-Generation Sequencing (NGS) Kits Sales Value by Application
  11. 5.3.1 Global Next-Generation Sequencing (NGS) Kits Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Application (2021-2032)
  13. 5.3.3 Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Application (2021-2032)
6 Next-Generation Sequencing (NGS) Kits Regional Sales and Value Analysis
  1. 6.1 Global Next-Generation Sequencing (NGS) Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Next-Generation Sequencing (NGS) Kits Sales by Region (2021-2032)
  3. 6.2.1 Global Next-Generation Sequencing (NGS) Kits Sales by Region: 2021-2026
  4. 6.2.2 Global Next-Generation Sequencing (NGS) Kits Sales by Region (2027-2032)
  5. 6.3 Global Next-Generation Sequencing (NGS) Kits Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Next-Generation Sequencing (NGS) Kits Sales Value by Region (2021-2032)
  7. 6.4.1 Global Next-Generation Sequencing (NGS) Kits Sales Value by Region: 2021-2026
  8. 6.4.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Region (2027-2032)
  9. 6.5 Global Next-Generation Sequencing (NGS) Kits Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032)
  12. 6.6.2 North America Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032)
  15. 6.7.2 Europe Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032)
  21. 6.9.2 South America Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Next-Generation Sequencing (NGS) Kits Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2025 VS 2032
7 Next-Generation Sequencing (NGS) Kits Country-level Sales and Value Analysis
  1. 7.1 Global Next-Generation Sequencing (NGS) Kits Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Next-Generation Sequencing (NGS) Kits Sales by Country (2021-2032)
  4. 7.3.1 Global Next-Generation Sequencing (NGS) Kits Sales by Country (2021-2026)
  5. 7.3.2 Global Next-Generation Sequencing (NGS) Kits Sales by Country (2027-2032)
  6. 7.4 Global Next-Generation Sequencing (NGS) Kits Sales Value by Country (2021-2032)
  7. 7.4.1 Global Next-Generation Sequencing (NGS) Kits Sales Value by Country (2021-2026)
  8. 7.4.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amoydxmed
  2. 8.1.1 Amoydxmed Company Information
  3. 8.1.2 Amoydxmed Business Overview
  4. 8.1.3 Amoydxmed Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amoydxmed Next-Generation Sequencing (NGS) Kits Product Portfolio
  6. 8.1.5 Amoydxmed Recent Developments
  7. 8.2 Foundation Medicine
  8. 8.2.1 Foundation Medicine Company Information
  9. 8.2.2 Foundation Medicine Business Overview
  10. 8.2.3 Foundation Medicine Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Foundation Medicine Next-Generation Sequencing (NGS) Kits Product Portfolio
  12. 8.2.5 Foundation Medicine Recent Developments
  13. 8.3 Illumina
  14. 8.3.1 Illumina Company Information
  15. 8.3.2 Illumina Business Overview
  16. 8.3.3 Illumina Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Illumina Next-Generation Sequencing (NGS) Kits Product Portfolio
  18. 8.3.5 Illumina Recent Developments
  19. 8.4 MSKCC
  20. 8.4.1 MSKCC Company Information
  21. 8.4.2 MSKCC Business Overview
  22. 8.4.3 MSKCC Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 MSKCC Next-Generation Sequencing (NGS) Kits Product Portfolio
  24. 8.4.5 MSKCC Recent Developments
  25. 8.5 Novogene
  26. 8.5.1 Novogene Company Information
  27. 8.5.2 Novogene Business Overview
  28. 8.5.3 Novogene Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novogene Next-Generation Sequencing (NGS) Kits Product Portfolio
  30. 8.5.5 Novogene Recent Developments
  31. 8.6 Nanjing Geneseeq
  32. 8.6.1 Nanjing Geneseeq Company Information
  33. 8.6.2 Nanjing Geneseeq Business Overview
  34. 8.6.3 Nanjing Geneseeq Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nanjing Geneseeq Next-Generation Sequencing (NGS) Kits Product Portfolio
  36. 8.6.5 Nanjing Geneseeq Recent Developments
  37. 8.7 Burning Rock Biotech
  38. 8.7.1 Burning Rock Biotech Company Information
  39. 8.7.2 Burning Rock Biotech Business Overview
  40. 8.7.3 Burning Rock Biotech Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Burning Rock Biotech Next-Generation Sequencing (NGS) Kits Product Portfolio
  42. 8.7.5 Burning Rock Biotech Recent Developments
  43. 8.8 Thermo Fisher Scientific
  44. 8.8.1 Thermo Fisher Scientific Company Information
  45. 8.8.2 Thermo Fisher Scientific Business Overview
  46. 8.8.3 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Kits Product Portfolio
  48. 8.8.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Next-Generation Sequencing (NGS) Kits Value Chain Analysis
  2. 9.1.1 Next-Generation Sequencing (NGS) Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Next-Generation Sequencing (NGS) Kits Sales Mode & Process
  6. 9.2 Next-Generation Sequencing (NGS) Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Next-Generation Sequencing (NGS) Kits Distributors
  9. 9.2.3 Next-Generation Sequencing (NGS) Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst